Arpimune ME is an immunosuppressive drug primarily used after organ transplants, such as kidney, liver, and heart transplants. It helps prevent the immune system from attacking the transplanted organ, thus reducing the likelihood of rejection. Doctors also prescribe it for some chronic autoimmune diseases, such as lupus, rheumatoid arthritis, and severe eye infections that do not respond to conventional treatments, making it a primary treatment in these cases.
This drug is effective in controlling immune reactions, as
Arpimune ME works to inhibit the activity of immune cells that cause excessive inflammation, thus alleviating the severity of symptoms and maintaining stable health. It should only be taken under the supervision of a specialist physician, adhering to the prescribed doses, and undergoing regular checkups to monitor liver and kidney function and blood pressure to reduce the risk of side effects and ensure optimal therapeutic benefit in a safe manner.